8-K/A

CURRENT REPORT AMENDMENT

Company: TENAX THERAPEUTICS, INC.
Filed: July 31, 2013
Period of Report: July 21, 2013
Accession Number: 0001354488-13-004138

View Document ↗ View on SEC.gov ↗